VM 26（4-去甲基-表鬼臼毒素-β-D-噻吨亚甲基葡萄糖苷）治疗膀胱肿瘤
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
作者信息
Mechl Z, Rovný F, Sopková B
出版信息
Neoplasma. 1977;24(4):411-4.
PMID:904743
Abstract
VM 26, a semisynthetic podophyllin derivative (4-demethyl-epipodo-phyllotoxin-beta-d-thenylidine glucoside) has been tested in 67 patients with urinary bladder tumors. In 25 patients with stage T 1 significant prolongation of the disease-free interval was reached. In 25 cases with state T 3-4, the effect of VM 26 was not favorable.
摘要
VM 26，一种半合成的鬼臼毒素衍生物（4-去甲基-表鬼臼毒素-β-D-噻吩甲基糖苷）已在67例膀胱肿瘤患者中进行了测试。在25例T1期患者中，无病间期显著延长。在25例T3-4期患者中，VM 26的效果不佳。
Zotero 插件